CRISAFULLI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 3.068
EU - Europa 2.603
AS - Asia 1.814
OC - Oceania 62
SA - Sud America 35
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.603
Nazione #
US - Stati Uniti d'America 2.976
CN - Cina 1.150
IT - Italia 1.138
GB - Regno Unito 241
DE - Germania 217
FR - Francia 201
JP - Giappone 201
SE - Svezia 123
IE - Irlanda 118
HK - Hong Kong 99
ES - Italia 91
IN - India 79
CA - Canada 70
FI - Finlandia 62
KR - Corea 60
TW - Taiwan 51
AU - Australia 43
BE - Belgio 43
NL - Olanda 42
PL - Polonia 41
UA - Ucraina 41
SG - Singapore 37
AT - Austria 34
DK - Danimarca 31
GR - Grecia 28
CH - Svizzera 27
IL - Israele 27
VN - Vietnam 23
MX - Messico 20
NO - Norvegia 20
CZ - Repubblica Ceca 19
HU - Ungheria 19
NZ - Nuova Zelanda 19
PT - Portogallo 17
BR - Brasile 16
TR - Turchia 15
RO - Romania 14
TH - Thailandia 11
AR - Argentina 10
RU - Federazione Russa 10
IR - Iran 9
AM - Armenia 8
MY - Malesia 8
BA - Bosnia-Erzegovina 7
HR - Croazia 6
ID - Indonesia 6
EG - Egitto 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
BN - Brunei Darussalam 4
KZ - Kazakistan 4
RS - Serbia 4
CL - Cile 3
CO - Colombia 3
CY - Cipro 3
PK - Pakistan 3
SA - Arabia Saudita 3
AP - ???statistics.table.value.countryCode.AP??? 2
DZ - Algeria 2
EU - Europa 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
PE - Perù 2
SN - Senegal 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
HN - Honduras 1
LK - Sri Lanka 1
PR - Porto Rico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 7.603
Città #
Ann Arbor 427
Chandler 275
Beijing 211
Shanghai 165
Redwood City 146
Houston 126
Torino 126
Fairfield 121
Guangzhou 120
Milan 109
Dublin 107
Ashburn 93
Turin 87
Cambridge 83
Woodbridge 79
Seattle 78
Wilmington 66
Tokyo 64
New York 62
Dearborn 61
Nyköping 46
Rome 45
Boston 44
Hangzhou 42
Nanjing 42
Wuhan 41
Pisa 36
Villeurbanne 34
Lappeenranta 33
Vienna 30
Carrara 29
London 28
Genoa 27
Medford 27
Paris 26
Taipei 25
Brussels 24
Los Angeles 24
Berlin 23
Central 23
Princeton 23
Jacksonville 22
Munich 22
San Diego 21
Central District 20
Fremont 20
Warsaw 20
Barcelona 19
Luni 19
Jinan 17
San Francisco 17
Duncan 16
Shenyang 16
Toulouse 16
Bologna 15
Buffalo 15
Chicago 15
Ottawa 15
Redmond 15
Tianjin 15
Changsha 14
Chengdu 14
Norwalk 14
Rochester 14
Toronto 14
Pittsburgh 13
Xian 13
Dallas 12
San Mateo 12
Seoul 12
Chongqing 11
Helsinki 11
Phoenix 11
Singapore 11
Somerville 11
Dong Ket 10
Grafing 10
Lyngby 10
Melbourne 10
Rehovot 10
Shenzhen 10
Zhengzhou 10
Baltimore 9
Birmingham 9
Budapest 9
Dunedin 9
Fuzhou 9
Hong Kong 9
Madrid 9
Mainz 9
Nanchang 9
Oslo 9
Palermo 9
Silver Spring 9
Simi Valley 9
Valencia 9
Washington 9
Chennai 8
Heidelberg 8
Hyderabad 8
Totale 4.029
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.662
Adaptive mutability of colorectal cancers in response to targeted therapies 1.603
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor 687
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology 538
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 413
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients 357
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer 277
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions 233
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor 214
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients 208
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer 189
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer 172
Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases 170
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 156
Tracking colorectal cancer evolution in time and space 147
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer 136
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination 80
Werner helicase is a synthetic-lethal vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy and Immunotherapy 76
Tumor heterogeneity and Lesion-Specific response to targeted therapy in colorectal cancer 73
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 62
Graves' disease prevalence in a young population with Turner syndrome 60
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer 52
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial 49
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study 49
Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients 41
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas 29
A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells 28
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient 11
Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation 10
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer 2
Totale 7.784
Categoria #
all - tutte 15.031
article - articoli 0
book - libri 0
conference - conferenze 265
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019127 0 0 0 0 0 0 0 0 0 0 77 50
2019/2020748 50 25 40 68 51 67 59 61 98 103 84 42
2020/20211.420 50 69 81 141 134 120 145 94 126 164 131 165
2021/20221.686 184 167 155 221 85 102 120 112 124 99 178 139
2022/20231.650 109 122 123 155 121 196 122 164 181 89 147 121
2023/20241.194 118 132 126 110 110 134 134 110 38 143 39 0
Totale 7.784